To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
Summit is developing ridinilazole as a novel antimicrobial for Clostridium difficile
Infection (CDI), formerly known as Clostridium difficile Infection, with the goal of
achieving comparable cure rates to standard of care, but reducing rates of recurrent disease.
...
Age: 18 years - 66+
Gender: All
Fecal Microbiota Transplant National Registry
A national data registry of patients receiving fecal microbiota transplantation (FMT) or
other gut-related-microbiota products designed to prospectively assess short and
long-term safety and effectiveness
Age: Birth - 66+
Gender: All
Fecal Microbiota Transplant National Registry
A national data registry of patients receiving fecal microbiota transplantation (FMT) or
other gut-related-microbiota products designed to prospectively assess short and
long-term safety and effectiveness
Age: Birth - 66+
Gender: All